These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28711140)

  • 1. Precision Medicine in Rheumatoid Arthritis.
    Bluett J; Barton A
    Rheum Dis Clin North Am; 2017 Aug; 43(3):377-387. PubMed ID: 28711140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate pharmacogenetics in rheumatoid arthritis.
    Brinker RR; Ranganathan P
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S33-9. PubMed ID: 21044431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
    Zhu H; Deng FY; Mo XB; Qiu YH; Lei SF
    Pharmacogenomics; 2014 Mar; 15(4):551-66. PubMed ID: 24624921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update.
    Ling SF; Bluett J
    Pharmacogenomics; 2020 Jan; 21(1):3-6. PubMed ID: 31849277
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetics of therapies in rheumatoid arthritis.
    Ranganathan P
    Drugs Today (Barc); 2005 Dec; 41(12):799-814. PubMed ID: 16474855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics in rheumatoid arthritis.
    Ranganathan P
    Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
    Taniguchi A; Urano W; Tanaka E; Kamatani N
    Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics.
    Conti V; Corbi G; Costantino M; De Bellis E; Manzo V; Sellitto C; Stefanelli B; Colucci F; Filippelli A
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33327600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on methotrexate pharmacogenetics in rheumatoid arthritis.
    Ranganathan P
    Pharmacogenomics; 2008 Apr; 9(4):439-51. PubMed ID: 18384257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate pharmacogenetics in the treatment of rheumatoid arthritis.
    Jekic B; Maksimovic N; Damnjanovic T
    Pharmacogenomics; 2019 Nov; 20(17):1235-1245. PubMed ID: 31648623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?
    Dervieux T
    J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics in rheumatoid arthritis.
    Sen D; Paul JR; Ranganathan P
    Methods Mol Biol; 2014; 1175():625-60. PubMed ID: 25150878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?
    Ranganathan P; Eisen S; Yokoyama WM; McLeod HL
    Ann Rheum Dis; 2003 Jan; 62(1):4-9. PubMed ID: 12480661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis].
    Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP
    Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal Treatment for Rheumatoid Arthritis with Companion Diagnostics].
    Kumagai S
    Rinsho Byori; 2015 Nov; 63(11):1328-35. PubMed ID: 26995880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in the genetic diagnostics of rheumatoid arthritis.
    Nagy ZB; Csanád M; Tóth K; Börzsönyi B; Demendi C; Rigó J; Joó JG
    Expert Rev Mol Diagn; 2010 Jul; 10(5):603-18. PubMed ID: 20629510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
    Lima A; Bernardes M; Azevedo R; Medeiros R; Seabra V
    Int J Mol Sci; 2015 Jun; 16(6):13760-80. PubMed ID: 26086825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine in rheumatoid arthritis: hopes and challenges.
    Bridges SL
    Bull NYU Hosp Jt Dis; 2007; 65(3):174-7. PubMed ID: 17922665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2)].
    Swierkot J; Slęzak R
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():207-15. PubMed ID: 21502697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents.
    Ranganathan P
    Curr Opin Mol Ther; 2008 Dec; 10(6):562-7. PubMed ID: 19051134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.